-
1
-
-
0028948839
-
Theoretical basis for a biopharmaceutical drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability
-
Amidon GL, Lennernas H, Shah VP, Crison JR. Theoretical basis for a biopharmaceutical drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995; 12(3):413–20.
-
(1995)
Pharm Res
, vol.12
, Issue.3
, pp. 413-420
-
-
Amidon, G.L.1
Lennernas, H.2
Shah, V.P.3
Crison, J.R.4
-
2
-
-
0002510887
-
Avoiding investment in doomed drugs, is poor solubility an industry wide problem?
-
Lipinski CA. Avoiding investment in doomed drugs, is poor solubility an industry wide problem? Curr Drug Dis 2001; 4:17–9.
-
(2001)
Curr Drug Dis
, vol.4
, pp. 17-19
-
-
Lipinski, C.A.1
-
3
-
-
0345468942
-
Disperse Systems
-
Banker GS, Rhodes CT, eds., 3rd edn. New York, NY: Marcel Dekker, Inc
-
Tabibi SE, Rhodes CT. Disperse Systems. In: Banker GS, Rhodes CT, eds. Modern Pharmaceutics, 3rd edn. New York, NY: Marcel Dekker, Inc.; 1996: 299–331.
-
(1996)
Modern Pharmaceutics
, pp. 299-331
-
-
Tabibi, S.E.1
Rhodes, C.T.2
-
4
-
-
0037151528
-
A novel particle engineering technology: Spray-freezing into liquid
-
Rogers TL, Hu JH, Yu ZS, Johnston KP, Williams III RO. A novel particle engineering technology: spray-freezing into liquid. Int J Pharm 2002; 242(1–2): 93–100.
-
(2002)
Int J Pharm
, vol.242
, Issue.1-2
, pp. 93-100
-
-
Rogers, T.L.1
Hu, J.H.2
Yu, Z.S.3
Johnston, K.P.4
Williams, R.O.5
-
5
-
-
1842559836
-
Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs
-
Hu J, Johnston KP, Williams III RO. Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs. Drug Dev Ind Pharm 2004; 30(3):233–45.
-
(2004)
Drug Dev Ind Pharm
, vol.30
, Issue.3
, pp. 233-245
-
-
Hu, J.1
Johnston, K.P.2
Williams, R.O.3
-
6
-
-
0034601240
-
Improving drug solubility for oral delivery using solid dispersions
-
Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharma Biopharm 2000; 50(1):47–60.
-
(2000)
Eur J Pharma Biopharm
, vol.50
, Issue.1
, pp. 47-60
-
-
Leuner, C.1
Dressman, J.2
-
7
-
-
0001927169
-
Supercritical antisolvent precipitation of micro-and nano-particles
-
Reverchon E. Supercritical antisolvent precipitation of micro-and nano-particles. J Supercrit Fluids 1999; 15(1):1–21.
-
(1999)
J Supercrit Fluids
, vol.15
, Issue.1
, pp. 1-21
-
-
Reverchon, E.1
-
8
-
-
0032771526
-
Phase behavioral effects on particle formation processes using supercritical fluids
-
Palakodaty S, York P. Phase behavioral effects on particle formation processes using supercritical fluids. Pharm Res 1999; 16(7):976–85.
-
(1999)
Pharm Res
, vol.16
, Issue.7
, pp. 976-985
-
-
Palakodaty, S.1
York, P.2
-
9
-
-
0001485045
-
Production of fine powders by the rapid expansion of supercritical fluid solutions
-
Matson DW, Peterson RC, Smith RD. Production of fine powders by the rapid expansion of supercritical fluid solutions. Adv Ceramics 1987; 21:109.
-
(1987)
Adv Ceramics
, vol.21
, pp. 109
-
-
Matson, D.W.1
Peterson, R.C.2
Smith, R.D.3
-
10
-
-
0027333734
-
Polymeric materials formed by precipitation with a compressed fluid antisolvent
-
Dixon DJ, Johnston KP, Bodmeier RA. Polymeric materials formed by precipitation with a compressed fluid antisolvent. AIChE J 1993; 39:127–39.
-
(1993)
Aiche J
, vol.39
, pp. 127-139
-
-
Dixon, D.J.1
Johnston, K.P.2
Bodmeier, R.A.3
-
11
-
-
0025817407
-
Atmospheric spray-freeze drying: A suitable alternative in freeze-drying technology
-
Mumenthaler M, Leuenberger H. Atmospheric spray-freeze drying: a suitable alternative in freeze-drying technology. Int J Pharm 1991; 72(2):97–110.
-
(1991)
Int J Pharm
, vol.72
, Issue.2
, pp. 97-110
-
-
Mumenthaler, M.1
Leuenberger, H.2
-
12
-
-
85022750938
-
Briggs AR, Maxwell TJ, inventors; Process for Preparing Powder Blends
-
Briggs AR, Maxwell TJ, inventors; Process for Preparing Powder Blends. US Patent 3,721,725. 1973.
-
(1973)
US Patent
, vol.3
, Issue.721
, pp. 725
-
-
-
13
-
-
0010754490
-
-
US Patent 3,653,222. 1972
-
Dunn DB, Masavage GJ, Sauer HA, inventors; Method of Freezing Solution Droplets and the Like Using Immiscible Refrigerants of Differing Densities. US Patent 3,653,222. 1972.
-
Inventors; Method of Freezing Solution Droplets and the like Using Immiscible Refrigerants of Differing Densities
-
-
Dunn, D.B.1
Masavage, G.J.2
Sauer, H.A.3
-
15
-
-
33847632965
-
Preparation of nanostructured particles of poorly water soluble drugs via a novel ultra-rapid freezing technology
-
Evans JC, Scherzer BD, Tocco CD, et al. Preparation of nanostructured particles of poorly water soluble drugs via a novel ultra-rapid freezing technology. Poly Mater Sci Eng (2003) 2003; 89:742.
-
(2003)
Poly Mater Sci Eng (2003)
, vol.89
, pp. 742
-
-
Evans, J.C.1
Scherzer, B.D.2
Tocco, C.D.3
-
16
-
-
0037373357
-
Properties of rapidly dissolving eutectic mixtures of poly(-ethylene glycol) and fenofibrate: The eutectic microstructure
-
Law D, Wang W, Schmitt EA, Qiu Y, Krill SL, Fort JJ. Properties of rapidly dissolving eutectic mixtures of poly(-ethylene glycol) and fenofibrate: the eutectic microstructure. J Pharm Sci 2003; 92:505–15.
-
(2003)
J Pharm Sci
, vol.92
, pp. 505-515
-
-
Law, D.1
Wang, W.2
Schmitt, E.A.3
Qiu, Y.4
Krill, S.L.5
Fort, J.J.6
-
17
-
-
9744245294
-
A new fenofibrate formulation: Results of six single-dose, clinical studies of bioavailability under fed and fasting conditions
-
Guivarc’h P-H, Vachon MG, Fordyce D. A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditions. Clin Ther 2004; 26(9):1456–69.
-
(2004)
Clin Ther
, vol.26
, Issue.9
, pp. 1456-1469
-
-
Guivarc’H, P.-H.1
Vachon, M.G.2
Fordyce, D.3
-
18
-
-
19444375996
-
Enhancement of oral bioavailability of poorly water-soluble drugs by poly(Ethylene glycol)-block-poly(alkyl acrylate-co-methacrylic acid) self-assemblies
-
Sant VP, Smith D, Leroux J-C. Enhancement of oral bioavailability of poorly water-soluble drugs by poly(ethylene glycol)-block-poly(alkyl acrylate-co-methacrylic acid) self-assemblies. J Control Release 2005; 104 (2):289–300.
-
(2005)
J Control Release
, vol.104
, Issue.2
, pp. 289-300
-
-
Sant, V.P.1
Smith, D.2
Leroux, J.-C.3
-
19
-
-
2942516895
-
Novel pH-sensitive supramolecular assemblies for oral delivery of poorly water soluble drugs: Preparation and characterization
-
Sant VP, Smith D, Leroux J-C. Novel pH-sensitive supramolecular assemblies for oral delivery of poorly water soluble drugs: preparation and characterization. J Control Release 2004; 97(2):301-12.
-
(2004)
J Control Release
, vol.97
, Issue.2
, pp. 301-312
-
-
Sant, V.P.1
Smith, D.2
Leroux, J.-C.3
-
20
-
-
21244445440
-
Spray-dried amorphous solid dispersions of simvastatin, a low Tg drug: In vitro and in vivo evaluations
-
Ambike AA, Mahadik KR, Paradkar A. Spray-dried amorphous solid dispersions of simvastatin, a low Tg drug: in vitro and in vivo evaluations. Pharm Res 2005; 22(6):990–8.
-
(2005)
Pharm Res
, vol.22
, Issue.6
, pp. 990-998
-
-
Ambike, A.A.1
Mahadik, K.R.2
Paradkar, A.3
-
21
-
-
0036173224
-
Improvement of solubility and oral bioavailability of a poorly water-soluble drug, TAS-301, by its melt-adsorption on a porous calcium silicate
-
Kinoshita M, Baba K, Nagayasu A, et al. Improvement of solubility and oral bioavailability of a poorly water-soluble drug, TAS-301, by its melt-adsorption on a porous calcium silicate. J Pharm Sci 2002; 91(2):362–70.
-
(2002)
J Pharm Sci
, vol.91
, Issue.2
, pp. 362-370
-
-
Kinoshita, M.1
Baba, K.2
Nagayasu, A.3
-
22
-
-
1942434656
-
The use of three different solid dispersion formulations – melt extrusion, film-coated beads, and a glass thermoplastic system – to improve the bioavailability of a novel microsomal triglyceride transfer protein inhibitor
-
Verreck G, Vandecruys R, De Conde V, Baert L, Peeters J, Brewster ME. The use of three different solid dispersion formulations – melt extrusion, film-coated beads, and a glass thermoplastic system – to improve the bioavailability of a novel microsomal triglyceride transfer protein inhibitor. J Pharm Sci 2004; 93(5):1217–28.
-
(2004)
J Pharm Sci
, vol.93
, Issue.5
, pp. 1217-1228
-
-
Verreck, G.1
Vandecruys, R.2
de Conde, V.3
Baert, L.4
Peeters, J.5
Brewster, M.E.6
-
23
-
-
1942434691
-
Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system
-
Dannenfelser R-M, He H, Joshi Y, Bateman S, Serajuddin ATM. Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system. J Pharm Sci 2004; 93(5):1165–75.
-
(2004)
J Pharm Sci
, vol.93
, Issue.5
, pp. 1165-1175
-
-
Dannenfelser, R.-M.1
He, H.2
Joshi, Y.3
Bateman, S.4
Serajuddin, A.T.M.5
-
24
-
-
0037422394
-
Effect of buffer media composition on the solubility and effective permeability coefficient of ibuprofen
-
Levis KA, Lane ME, Corrigan OI. Effect of buffer media composition on the solubility and effective permeability coefficient of ibuprofen. Int J Pharm 2003; 6:49–59.
-
(2003)
Int J Pharm
, vol.6
, pp. 49-59
-
-
Levis, K.A.1
Lane, M.E.2
Corrigan, O.I.3
-
26
-
-
23944496082
-
Ibuprofen extrudate, a novel, rapidly dissolving ibuprofen formulation: Relative bioavailability compared to ibuprofen lysinate and regular ibuprofen, and food effect on all formulations
-
Klueglich M, Ring A, Scheuerer S, et al. Ibuprofen extrudate, a novel, rapidly dissolving ibuprofen formulation: relative bioavailability compared to ibuprofen lysinate and regular ibuprofen, and food effect on all formulations. J Clin Pharmacol 2005; 45(9):1055–61.
-
(2005)
J Clin Pharmacol
, vol.45
, Issue.9
, pp. 1055-1061
-
-
Klueglich, M.1
Ring, A.2
Scheuerer, S.3
-
27
-
-
85056952695
-
Solid Solutions for Insoluble Substances
-
Spring/Summer
-
Lewis J. Solid Solutions for Insoluble Substances. Drug Delivery Report 2006; Spring/Summer:62–3.
-
(2006)
Drug Delivery Report
, pp. 62-63
-
-
Lewis, J.1
-
29
-
-
0024390397
-
Therapeutically relevant differences in the pharmacokinetical and pharmceutical behavior of ibuprofen lysinate as compared to ibuprofen acid
-
Geisslinger G, Dietzel K, Bezler H, Nuernberg B, Brune K. Therapeutically relevant differences in the pharmacokinetical and pharmceutical behavior of ibuprofen lysinate as compared to ibuprofen acid. Int J Clin Pharmacol Ther Toxicol 1989; 27:324–8.
-
(1989)
Int J Clin Pharmacol Ther Toxicol
, vol.27
, pp. 324-328
-
-
Geisslinger, G.1
Dietzel, K.2
Bezler, H.3
Nuernberg, B.4
Brune, K.5
-
30
-
-
84862448681
-
The discovery and characterization of selective cyclooxygenase-2 inhibitors
-
Bell R, Black L, Harries R, et al. The discovery and characterization of selective cyclooxygenase-2 inhibitors. Inflamm Res 2000; 49:S101.
-
(2000)
Inflamm Res
, vol.49
, pp. S101
-
-
Bell, R.1
Black, L.2
Harries, R.3
-
31
-
-
6944243071
-
Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68
-
Chen Y, Zhang GGZ, Neilly J, Marsh K, Mawhinney D, Sanzgiri YD. Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68. Int J Pharm 2004; 286(1–2):69–80.
-
(2004)
Int J Pharm
, vol.286
, Issue.1-2
, pp. 69-80
-
-
Chen, Y.1
Zhang, G.G.Z.2
Neilly, J.3
Marsh, K.4
Mawhinney, D.5
Sanzgiri, Y.D.6
-
32
-
-
85056971657
-
-
Washington, DC: American Pharmaceutical Association
-
Collett JH, Popli H. Poloxamer. Washington, DC: American Pharmaceutical Association; 2001.
-
(2001)
Poloxamer
-
-
Collett, J.H.1
Popli, H.2
-
33
-
-
0031395859
-
Physicochemical characterizations of piroxicam-poloxamer solid dispersion
-
Shin SC, Cho CW. Physicochemical characterizations of piroxicam-poloxamer solid dispersion. Pharm Dev Tech 1997; 2:403–7.
-
(1997)
Pharm Dev Tech
, vol.2
, pp. 403-407
-
-
Shin, S.C.1
Cho, C.W.2
-
34
-
-
0036166898
-
Preparation and characterization of ibuprofen-poloxamer 188 granules obtained by melt granulation
-
Passerini N, Albertini B, Gonzoalez-Rodro guez ML, Cavallari C, Rodriguez L. Preparation and characterization of ibuprofen-poloxamer 188 granules obtained by melt granulation. Eur J Pharm Sci; 2002:71–8.
-
(2002)
Eur J Pharm Sci
, pp. 71-78
-
-
Passerini, N.1
Albertini, B.2
Gonzoalez-Rodro Guez, M.L.3
Cavallari, C.4
Rodriguez, L.5
-
35
-
-
0028218199
-
Dissolution, bioavailability and ulcerogenic studies on solid dispersions of indomethacin in water-soluble cellulose polymers
-
Chowdary KPR, Babu KVVS. Dissolution, bioavailability and ulcerogenic studies on solid dispersions of indomethacin in water-soluble cellulose polymers. Drug Dev Ind Pharm 1994; 20(5):799–813.
-
(1994)
Drug Dev Ind Pharm
, vol.20
, Issue.5
, pp. 799-813
-
-
Chowdary, K.P.R.1
Babu, K.V.V.S.2
-
36
-
-
0032971677
-
Pharmacokinetic profile and adverse gastric effect of zinc-piroxicam in rats
-
Tagliati CA, Kimura E, Nothenberg MS, Santos SRJC, Oga S. Pharmacokinetic profile and adverse gastric effect of zinc-piroxicam in rats. Gen Pharmacol 1999; 13:67–71.
-
(1999)
Gen Pharmacol
, vol.13
, pp. 67-71
-
-
Tagliati, C.A.1
Kimura, E.2
Nothenberg, M.S.3
Santos, S.R.J.C.4
Oga, S.5
-
37
-
-
0242320527
-
Enhanced bioavailability of piroxicam using Gelucire 44/14 and Labrasol: In vitro and in vivo evaluation
-
Yuksel N, Karatas A, Ozkan Y, Savaser A, Ozkan SA, Baykara T. Enhanced bioavailability of piroxicam using Gelucire 44/14 and Labrasol: in vitro and in vivo evaluation. Eur J Pharma Biopharm 2003; 56(3):453–9.
-
(2003)
Eur J Pharma Biopharm
, vol.56
, Issue.3
, pp. 453-459
-
-
Yuksel, N.1
Karatas, A.2
Ozkan, Y.3
Savaser, A.4
Ozkan, S.A.5
Baykara, T.6
-
38
-
-
0026322580
-
Improved bioavailability of a new oral preparation of medroxyprogesterone acetate
-
Etienne MC, Milano G, Rene N, et al. Improved bioavailability of a new oral preparation of medroxyprogesterone acetate. J Pharm Sci 1991; 80(12):1130–2.
-
(1991)
J Pharm Sci
, vol.80
, Issue.12
, pp. 1130-1132
-
-
Etienne, M.C.1
Milano, G.2
Rene, N.3
-
41
-
-
0021485703
-
An evaluation of high-close medroxyprogesterone acetate therapy in women with advanced breast cancer
-
Johnson JR, Priestman IJ, Fotherby K, Kelly KA, Priestman SG. An evaluation of high-close medroxyprogesterone acetate therapy in women with advanced breast cancer. Br J Cancer 1984; 1984(50):363–6.
-
(1984)
Br J Cancer
, vol.1984
, Issue.50
, pp. 363-366
-
-
Johnson, J.R.1
Priestman, I.J.2
Fotherby, K.3
Kelly, K.A.4
Priestman, S.G.5
-
42
-
-
0028337031
-
Improved oral absorption of enteric coprecipitates of a poorly soluble drug
-
Kondo N, Iwao T, Hirai K, et al. Improved oral absorption of enteric coprecipitates of a poorly soluble drug. J Pharm Sci 1994; 83(4):566–70.
-
(1994)
J Pharm Sci
, vol.83
, Issue.4
, pp. 566-570
-
-
Kondo, N.1
Iwao, T.2
Hirai, K.3
-
43
-
-
0027421578
-
Pharmacokinetics of a micronized, poorly water-soluble drug, HO-221, in experimental animals
-
Kondo N, Iwao T, Kikuchi M, et al. Pharmacokinetics of a micronized, poorly water-soluble drug, HO-221, in experimental animals. Biol Pharm Bull 1993; 16 (8):796–800.
-
(1993)
Biol Pharm Bull
, vol.16
, Issue.8
, pp. 796-800
-
-
Kondo, N.1
Iwao, T.2
Kikuchi, M.3
-
44
-
-
0036446123
-
Lonidamine Solid dispersions: In vitro and in vivo evaluation
-
Palmieri GF, Cantalamessa F, Di Martino P, Nasuti C, Martelli S. Lonidamine Solid dispersions: in vitro and in vivo evaluation. Drug Dev Ind Pharm 2002; 28 (10):1241–50.
-
(2002)
Drug Dev Ind Pharm
, vol.28
, Issue.10
, pp. 1241-1250
-
-
Palmieri, G.F.1
Cantalamessa, F.2
Di Martino, P.3
Nasuti, C.4
Martelli, S.5
-
47
-
-
1542410398
-
Ritonavir-PEG 8000 amorphous solid dispersions: In vitro and in vivo evaluations
-
Law D, Schmitt EA, Marsh KC, et al. Ritonavir-PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluations. J Pharm Sci 2004; 93(3):563–70.
-
(2004)
J Pharm Sci
, vol.93
, Issue.3
, pp. 563-570
-
-
Law, D.1
Schmitt, E.A.2
Marsh, K.C.3
-
48
-
-
0034886795
-
Physicochemical considerations in the preparation of amorphous ritonavir/PEG 8000 solid dispersions
-
Law D, Krill SL, Schmitt EA, et al. Physicochemical considerations in the preparation of amorphous ritonavir/PEG 8000 solid dispersions. J Pharm Sci 2001; 90(8):1015–25.
-
(2001)
J Pharm Sci
, vol.90
, Issue.8
, pp. 1015-1025
-
-
Law, D.1
Krill, S.L.2
Schmitt, E.A.3
-
49
-
-
0033634987
-
The influence of donor and reservoir additives on Caco-2 permeability and secretory transport of HIV protease inhibitors and other lipophilic compounds
-
Aungst BJ, Nguyen NH, Bulgarelli JP, Oates-Lenz K. The influence of donor and reservoir additives on Caco-2 permeability and secretory transport of HIV protease inhibitors and other lipophilic compounds. Pharm Res 2000; 17: 1175–80.
-
(2000)
Pharm Res
, vol.17
, pp. 1175-1180
-
-
Aungst, B.J.1
Nguyen, N.H.2
Bulgarelli, J.P.3
Oates-Lenz, K.4
-
50
-
-
0343953614
-
Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: Effect of the particle size and nutritional state
-
De Jaeghere F, Allemann E, Kubel F, et al. Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state. J Control Release 2000; 68(2):291–8.
-
(2000)
J Control Release
, vol.68
, Issue.2
, pp. 291-298
-
-
de Jaeghere, F.1
Allemann, E.2
Kubel, F.3
-
52
-
-
19944432124
-
Clinical study of solid dispersions of itraconazole prepared by hot-stage extrusion
-
Six K, Daems T, de Hoon J, et al. Clinical study of solid dispersions of itraconazole prepared by hot-stage extrusion. Eur J Pharm Sci 2005; 24(2-3): 179–86.
-
(2005)
Eur J Pharm Sci
, vol.24
, Issue.2-3
, pp. 179-186
-
-
Six, K.1
Daems, T.2
de Hoon, J.3
-
53
-
-
0036278959
-
Characterization of the interaction of 2-hydroxypropyl-B-cyclodextrin with itraconazole at pH 2, 4 and 7
-
Peeters J, Neeskens P, Tollenaere JP, Van Remoortere P, Brewster M. Characterization of the interaction of 2-hydroxypropyl-B-cyclodextrin with itraconazole at pH 2, 4 and 7. J Pharm Sci 2002; 91:1414–22.
-
(2002)
J Pharm Sci
, vol.91
, pp. 1414-1422
-
-
Peeters, J.1
Neeskens, P.2
Tollenaere, J.P.3
van Remoortere, P.4
Brewster, M.5
-
55
-
-
0026596106
-
Clinical pharmacokinetics of albendazole in patients with brain cysticercosis
-
Jung H, Hurtado M, Sanchez M, Medina MY, Sotelo J. Clinical pharmacokinetics of albendazole in patients with brain cysticercosis. J Clin Pharmacol 1992; 32:28–31.
-
(1992)
J Clin Pharmacol
, vol.32
, pp. 28-31
-
-
Jung, H.1
Hurtado, M.2
Sanchez, M.3
Medina, M.Y.4
Sotelo, J.5
-
56
-
-
0031745410
-
Effect of gastric pH on the bioavailability of albendazole
-
Kohri N, Yamayoshi Y, Iseki K, Sato N, Todo S, Miyazaki K. Effect of gastric pH on the bioavailability of albendazole. Pharm Pharmacol Commun 1998; 4: 267–70.
-
(1998)
Pharm Pharmacol Commun
, vol.4
, pp. 267-270
-
-
Kohri, N.1
Yamayoshi, Y.2
Iseki, K.3
Sato, N.4
Todo, S.5
Miyazaki, K.6
-
57
-
-
0032997934
-
Improving the oral bioavailability of albendazole in rabbits by the solid dispersion technique
-
Kohri N, Yamayoshi Y, Xin H, et al. Improving the oral bioavailability of albendazole in rabbits by the solid dispersion technique. J Pharm Pharmacol 1999; 51(2):159–64.
-
(1999)
J Pharm Pharmacol
, vol.51
, Issue.2
, pp. 159-164
-
-
Kohri, N.1
Yamayoshi, Y.2
Xin, H.3
-
58
-
-
85056959391
-
Mosby’s Drug Consult. 16 edn. St. Louis, Missouri: Mosby
-
Maheswaran AM, ed
-
Maheswaran AM, ed. Mosby’s Drug Consult. 16 edn. St. Louis, Missouri: Mosby, Inc.; 2006.
-
(2006)
Inc.
-
-
-
59
-
-
3843097202
-
Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system
-
Lindenberg M, Kopp S, Dressman JB. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. Eur J Pharma Biopharm 2004; 58(2):265–78.
-
(2004)
Eur J Pharma Biopharm
, vol.58
, Issue.2
, pp. 265-278
-
-
Lindenberg, M.1
Kopp, S.2
Dressman, J.B.3
-
60
-
-
33744974493
-
Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles
-
Wong SM, Kellaway IW, Murdan S. Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles. Int J Pharm 2006; 317(1):61–8.
-
(2006)
Int J Pharm
, vol.317
, Issue.1
, pp. 61-68
-
-
Wong, S.M.1
Kellaway, I.W.2
Murdan, S.3
-
61
-
-
0009470340
-
Physico-chemical properties of (–)-1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-17-allyl-1,14-dihy-droxy-12-[(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetrametyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9] octacos-18-ene-2,3,10,16-tetrone hydrate (FK-506)
-
Hane K, Fujioka M, Namiki Y, et al. Physico-chemical properties of (–)-1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R-17-allyl-1,14-dihy-droxy-12-[(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetrametyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9] octacos-18-ene-2,3,10,16-tetrone hydrate (FK-506). Iyakuhin Kenkyu 1992; 23: 33–43.
-
(1992)
Iyakuhin Kenkyu
, vol.23
, pp. 33-43
-
-
Hane, K.1
Fujioka, M.2
Namiki, Y.3
-
62
-
-
0023630934
-
The oral dosage form of FK-506
-
Honbo T, Kobayashi M, Hane K, Hata T, Ueda Y. The oral dosage form of FK-506. Transpl Proc 1987; 19:17–22.
-
(1987)
Transpl Proc
, vol.19
, pp. 17-22
-
-
Honbo, T.1
Kobayashi, M.2
Hane, K.3
Hata, T.4
Ueda, Y.5
-
63
-
-
0242266530
-
Establishment of new preparation method for solid dispersion formulation of tacrolimus
-
Yamashita K, Nakate T, Okimoto K, et al. Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int J Pharm 2003; 267 (1–2):79–91.
-
(2003)
Int J Pharm
, vol.267
, Issue.1-2
, pp. 79-91
-
-
Yamashita, K.1
Nakate, T.2
Okimoto, K.3
-
66
-
-
32344439711
-
Enhancing the Bioavailability of Cyclosporine A Using Solid Dispersion Containing Polyoxyethylene (40) Stearate
-
Liu C, Wu J, Shi B, Zhang Y, Gao T, Pei Y. Enhancing the Bioavailability of Cyclosporine A Using Solid Dispersion Containing Polyoxyethylene (40) Stearate. Drug Dev Ind Pharm 2006; 32(1):115–23.
-
(2006)
Drug Dev Ind Pharm
, vol.32
, Issue.1
, pp. 115-123
-
-
Liu, C.1
Wu, J.2
Shi, B.3
Zhang, Y.4
Gao, T.5
Pei, Y.6
-
67
-
-
33745590868
-
Supersaturation produces high bioavailability of amorphous danazol particles formed by evaporative precipitation into aqueous solution and spray freezing into liquid technologies
-
Vaughn JM, T. MJ, Crisp MT, Johnston KP, Williams RO, III. Supersaturation produces high bioavailability of amorphous danazol particles formed by evaporative precipitation into aqueous solution and spray freezing into liquid technologies. Drug Dev Ind Pharm 2006; 32(5):559–67.
-
(2006)
Drug Dev Ind Pharm
, vol.32
, Issue.5
, pp. 559-567
-
-
Vaughn, J.M.1
Mj, T.2
Crisp, M.T.3
Johnston, K.P.4
Williams, R.O.5
-
68
-
-
0037189994
-
Enhanced drug dissolution using evaporative precipitation into aqueous solution
-
Sarkari M, Brown J, Chen XX, Swinnea S, Williams RO, Johnston KP. Enhanced drug dissolution using evaporative precipitation into aqueous solution. Int J Pharm 2002; 243(1–2):17–31.
-
(2002)
Int J Pharm
, vol.243
, Issue.1-2
, pp. 17-31
-
-
Sarkari, M.1
Brown, J.2
Chen, X.X.3
Swinnea, S.4
Williams, R.O.5
Johnston, K.P.6
-
69
-
-
0021744110
-
Particle size dependency of dissolution rate and human bioavailability of phenytoin in powders and phenytoin-polyethylene glycol solid dispersions
-
Yakou S, Umehara K, Sonobe T, Nagai T, Sugihara M, Fukuyama Y. Particle size dependency of dissolution rate and human bioavailability of phenytoin in powders and phenytoin-polyethylene glycol solid dispersions. Chem Pharm Bull 1984; 32(10):4130–6.
-
(1984)
Chem Pharm Bull
, vol.32
, Issue.10
, pp. 4130-4136
-
-
Yakou, S.1
Umehara, K.2
Sonobe, T.3
Nagai, T.4
Sugihara, M.5
Fukuyama, Y.6
-
70
-
-
0024604891
-
The in-vitro pH-dissolution dependence and in-vivo bioavailability of frusemide-PVP solid dispersions
-
Doherty C, York P. The in-vitro pH-dissolution dependence and in-vivo bioavailability of frusemide-PVP solid dispersions. J Pharm Pharmacol 1989; 41(2):73–8.
-
(1989)
J Pharm Pharmacol
, vol.41
, Issue.2
, pp. 73-78
-
-
Doherty, C.1
York, P.2
-
71
-
-
3142754096
-
In vitro and in vivo evaluation of glibenclamide in solid dispersion systems
-
Tashtoush BM, Al-Qashi ZS, Najib NM. In vitro and in vivo evaluation of glibenclamide in solid dispersion systems. Drug Dev Ind Pharm 2004; 30(6): 601–7.
-
(2004)
Drug Dev Ind Pharm
, vol.30
, Issue.6
, pp. 601-607
-
-
Tashtoush, B.M.1
Al-Qashi, Z.S.2
Najib, N.M.3
-
72
-
-
0032885450
-
Solid disperison of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs
-
Serajuddin ATM. Solid disperison of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 1999; 88(10):1058–66.
-
(1999)
J Pharm Sci
, vol.88
, Issue.10
, pp. 1058-1066
-
-
Serajuddin, A.T.M.1
|